Agenus Reports 51% 18-Month Survival With BOT+BAL in MSS Colorectal Cancer
SIOG 2026: 15 Posts Not to Miss from the Annual Conference in Valencia
Cesaltina Lorenzoni: Cancer Care Challenges in African Conflict Zones at LGCW 2026
SABR Versus Surgery in Early-Stage NSCLC: New JCO Study Supports Surgical Resection, With Important Questions for Older Patients
Kim Nichols Shares New Guideline on Genetic Testing for Childhood Cancer Survivors
UNICORN Phase 2: Neoadjuvant Botensilimab Plus Balstilimab Shows Promising Activity in pMMR and dMMR Colon Cancer
ESMO 2026 Reshapes Metastatic Breast Cancer Treatment: ADCs Move Into First Line as Biomarkers Guide New Strategies
Pharma CEOs Meet in New York: What's at Stake for Cancer Drugs?
